Immediate Impact
61 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
Works of Nadia Raban being referenced
The CHIVA study: a GINECO randomized double blind phase II trial of nintedanib versus placebo with the neo-adjuvant chemotherapy (NACT) strategy for patients (pts) with advanced unresectable ovarian cancer (OC). Report of the interval debulking surgery (IDS) safety outcome
2016
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Nadia Raban | 61 | 46 | 42 | 16 | 140 | |
| Bruno Chiurazzi | 49 | 33 | 31 | 12 | 113 | |
| Qingyi Wang | 58 | 11 | 27 | 24 | 151 | |
| Ramya Varadarajan | 56 | 17 | 9 | 11 | 146 | |
| Anmol Baranwal | 23 | 26 | 17 | 23 | 187 | |
| M. Luque | 37 | 10 | 43 | 22 | 175 | |
| Philippe Huot-Marchand | 30 | 19 | 38 | 13 | 197 | |
| Heather C. Murray | 33 | 26 | 97 | 14 | 198 | |
| Hans Ulrich Ulmer | 32 | 6 | 39 | 12 | 145 | |
| Heather Miller | 25 | 39 | 53 | 20 | 144 | |
| Charlotte H. J. R. Jansen | 36 | 27 | 55 | 16 | 221 |
All Works
Loading papers...